Bettuzzi, Thomas et al. “Incidence, In-Hospital and Long-Term Mortality, and Sequelae of Epidermal Necrolysis in Adults.”
JAMA dermatology, e243575. 2 Oct. 2024, doi:10.1001/jamadermatol.2024.3575

Nicol, Edith et al. “Preformulation evaluation of selumetinib for topical application: skin distribution and photodegradation analysis using MALDI imaging and LC-MS/MS.”
Pharmaceutical development and technology vol. 29,8 (2024): 855-861. doi:10.1080/10837450.2024.2405829

Pacot, Laurence et al. “Prenatal diagnosis for neurofibromatosis type 1 and the pitfalls of germline mosaics.”
NPJ genomic medicine vol. 9,1 41. 8 Sep. 2024, doi:10.1038/s41525-024-00425-9

Leboyer, Marion et al. “Low-dose interleukin-2 in patients with bipolar depression: A phase 2 randomised double-blind placebo-controlled trial.”
Brain, behavior, and immunity, vol. 123 177-184. 4 Sep. 2024, doi:10.1016/j.bbi.2024.09.005

Fontana, Marianna et al. “Vutrisiran in Patients with Transthyretin Amyloidosis with Cardiomyopathy.”
The New England journal of medicine, 10.1056/NEJMoa2409134. 30 Aug. 2024, doi:10.1056/NEJMoa2409134

Skorobogatov, Katrien et al. “Immune-based Machine learning Prediction of Diagnosis and Illness State in Schizophrenia and Bipolar Disorder.”
Brain, behavior, and immunity vol. 122 (2024): 422-432. doi:10.1016/j.bbi.2024.08.013

Pina Vegas, Laura et al. “Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS).”
RMD open vol. 10,3 e004631. 7 Aug. 2024, doi:10.1136/rmdopen-2024-004631

Boukouaci, Wahid et al. “B Cell-activating factor (BAFF): A promising trans-nosographic biomarker of inflammation and autoimmunity in bipolar disorder and schizophrenia.”
Brain, behavior, and immunity vol. 121 (2024): 178-188. doi:10.1016/j.bbi.2024.07.025